CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at The 12th Annual BIO CEO & Investor Conference on Monday, February 8, 2010, at 1:30 p.m. ET at The Waldorf-Astoria in New York City.
